GT Biopharma (GTBP) Experiencing Abnormally High Short Selling

Published in Stocks and Investing on Tuesday, July 8th 2025 at 4:10 GMT by WOPRAI
^{🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source}

The chart below shows ALL of the short selling each day in GT BIOPHARMA, INC. (GTBP). We have consolidated the tape of ALL US stock exchanges and dark pools (this means we get the TRADE IDENTIFIER showing whether the trade was a buy, sell or sell short). The data below shows just the short sales each day in your stock. It includes both EXEMPT (market makers) and NON-EXEMPT (everyone else) short sales in GT BIOPHARMA, INC.. An average of 40.67% of the daily trading in GTBP is short selling. This is abnormally high and implies there is illicit trading taking place in your stock. We run automated surveillance and reporting algorithms that report manipulative market making and short selling (to FINRA, SEC, Whistleblower's Office and Dept of Treasury FINCEN). We then issue FINRA COMPLIANT research to our large user base to counteract this activity that is driving GTBP lower unfairly.

You can find the full report at [ https://www.woprai.com/ ]

Please find the applicable data below, drawn from all major market providers.

Date	Short Volume	Total Volume	Percentage	Squeeze Trigger	$ Value
2025-07-07	95,197	475,464	20.02	2.22	211,337
2025-07-03	19,523	125,502	15.56	2.82	55,055
2025-07-02	37,835	85,593	44.2	3.18	120,315
2025-07-01	10,260	43,476	23.6	3.52	36,115
2025-06-30	16,995	56,589	30.03	3.58	60,842
2025-06-27	20,370	69,030	29.51	3.59	73,128
2025-06-26	61,759	211,393	29.22	3.66	226,038
2025-06-25	59,971	181,409	33.06	3.57	214,096
2025-06-24	53,645	103,894	51.63	3.3	177,029
2025-06-23	46,704	69,453	67.25	3.06	142,914
2025-06-20	4,859	17,891	27.16	3.02	14,674
2025-06-18	9,858	25,169	39.17	2.87	28,292
2025-06-17	10,317	38,415	26.86	2.81	28,991
2025-06-16	19,262	57,490	33.5	2.83	54,511
2025-06-13	26,463	67,228	39.36	2.88	76,213
2025-06-12	29,250	75,053	38.97	3.01	88,043
2025-06-11	61,465	112,049	54.86	3.14	193,000
2025-06-10	43,841	98,539	44.49	3.04	133,277
2025-06-09	130,719	216,755	60.31	2.97	388,235
2025-06-06	8,526	20,396	41.8	2.68	22,850
2025-06-05	4,940	18,614	26.54	2.68	13,239
2025-06-04	12,570	28,903	43.49	2.75	34,568
2025-06-03	7,774	20,646	37.65	2.76	21,456
2025-06-02	12,133	25,152	48.24	2.63	31,910
2025-05-30	16,956	30,978	54.74	2.63	44,594
2025-05-29	15,475	26,164	59.15	2.83	43,794
2025-05-28	14,246	42,801	33.28	2.84	40,459
2025-05-27	50,853	99,935	50.89	2.79	141,880
2025-05-23	34,672	100,292	34.57	2.78	96,388
2025-05-22	70,623	195,478	36.13	2.65	187,151
2025-05-21	221,182	457,808	48.31	2.62	579,497
2025-05-20	33,745	62,598	53.91	2.19	73,902
2025-05-19	260,810	530,163	49.19	2.48	646,809
2025-05-16	657	5,129	12.81	2.24	1,472
2025-05-15	1,710	2,791	61.27	2.25	3,848
2025-05-14	3,283	9,772	33.6	2.27	7,452
2025-05-13	3,436	15,284	22.48	2.2	7,559

Total	166,160,351	408,408,132	40.68	4.51	748,705,092

* Totals include all data records back to 2020-07-09 00:00:00, data set is truncated for viewing.

N※N

GT Biopharma (GTBP) Experiencing Abnormally High Short Selling